SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 1, 2026

RAPP

Rapport Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $368K total
Actionable Insight • Neutral

Insider sales are well below the 0.1% market-cap materiality threshold and are not clustered with any non-routine event. Per the literature, single-filing insider sales of this size carry negligible predictive power. Monitor for a material decline only if accompanied by a fundamental catalyst such as pipeline data readouts or guidance changes.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
RAPP ▼ -14.19% at T+60d
NEUTRAL call ✗ call lost -14.19% · α vs SPY -16.99% · entry $38.97 → $33.44
Entry anchored
Jul 1, 04:00 PM ET
via 1-min bar
T+1d
-1.03%
call -1.03% · α -1.90%
$38.57
settled 4mo ago
T+5d
+7.13%
call +7.13% · α +5.77%
$41.75
settled 4mo ago
T+20d
+5.16%
call +5.16% · α +4.86%
$40.98
settled 3mo ago
T+60d
-14.19%
call -14.19% · α -16.99%
$33.44
settled 4w ago

Price Chart

Loading chart...

Executive Summary

CEO Abraham Ceesay and COO Cheryl Gault sold a combined ~$368K worth of RAPP shares in open-market transactions on June 29-30, 2026. The total value represents ~0.02% of the $1.9B market cap and falls well below the 0.1% proportionality threshold, making it a trivial, routine insider sale. No non-cash transactions or unusual clustering patterns are present.

Key Financial Metrics

Direction
selling
Total Value
$368.0K
Insiders
2

Key Facts

  • CEO Abraham Ceesay sold 7,344 shares at ~$39.77 for ~$292K on June 29, 2026.
  • COO Cheryl Gault sold 1,900 shares at ~$40.09 for ~$76K on June 30, 2026.
  • Total cluster value of ~$368K is ~0.02% of RAPP's $1.9B market cap.
  • No open-market purchases were reported in the cluster window.

Financial Impact

Approximately $368K in insider sales, representing ~0.02% of market cap.

insider ownershipdilution

Risk Factors

  • Insider sales, though small, could precede or coincide with negative news not yet public.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RAPP-1782977685523
22 reports for RAPP
Performance horizon
67% Hit rate @ T+5 4 of 6 directional calls Went positive at some point 6 of 8 best @ T+60▲ +24.87%Mar 10, 2026
Filters
Rows
Reports for RAPP — sortable, filterable
TypeNow
Oct 23, 2026
2d ago
Insider Cluster
BULLISH ★ 5/10
$26.00awaiting T+5—$25.93 (−0.27%)
Oct 22, 2026
4d ago
Insider Cluster
BULLISH ★ 5/10
$27.33awaiting T+5—$25.93 (−5.12%)
Oct 21, 2026
4d ago
Insider Buy
BULLISH ★ 4/10
$26.53awaiting T+5—$25.93 (−2.26%)
Oct 20, 2026
6d ago
8-K
BULLISH ★ 7/10
$29.37awaiting T+5—$25.93 (−11.71%)
Oct 6, 2026
19d ago
144
BEARISH ★ 5/10
$30.86 $28.33▲ +8.20%▲ +7.22%$25.93 (+15.98%)
Oct 1, 2026
24d ago
Insider Cluster
NEUTRAL ★ 3/10
$32.17 $30.65▼ −4.72%▼ −5.89%$25.93 (−19.40%)
Aug 26, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.83 $47.65▼ −6.26%▼ −6.52%$25.93 (−48.99%)
Aug 5, 2026
11w ago
8-K
MIXED ★ 5/10
$42.44 $47.73▲ +12.46%▲ +12.11%$25.93 (−38.90%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$38.97 $41.75▲ +7.13%▲ +5.77%$25.93 (−33.46%)
Jun 30, 2026
16w ago
144
NEUTRAL ★ 2/10
$39.39 $39.72▲ +0.84%▲ +0.58%$25.93 (−34.17%)
Showing 10 of 22

US Market Status

Market Closed — Opens in 2h 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026